Dr Amir Englund has a PhD in Cannabinoid Psychopharamcology from the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Over the last decade he has conducted several experimental psychopharmacology studies using cannabinoid in healthy volunteers as well as clinical trials with CBD as a treatment for psychosis.